Viracta Therapeutics, Inc.
USD0.01
+0.00 (+0.00%)
CEO
Craig R. Jalbert
IPO Date
2005-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.19
Market Cap
$0.00B
| -1.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -215.2% | -187.1% | 0.06 | 11.59 | -0.6 |
| 31 Dec 2020 | FY | 73.3% | -15999.2% | 41.6% | -39.7% | -0.13 | 7.51 | -13.5 |
| 31 Dec 2019 | FY | 100.0% | -1125.4% | -84.7% | -62.6% | 0.23 | 3.86 | -12.3 |
| 31 Dec 2018 | FY | 480.9% | -11230.0% | -666.5% | -173.7% | 1.85 | 1.34 | -0.6 |
| 31 Dec 2017 | FY | 98.7% | -5300.1% | -164.6% | -103.3% | 0.33 | 2.60 | -2.6 |
| 31 Dec 2016 | FY | 100.0% | -1499.3% | -180.9% | -87.9% | 0.69 | 3.95 | -6.7 |
| 31 Dec 2015 | FY | 100.0% | -1198.2% | -133.9% | -78.0% | 0.29 | 2.47 | -7.0 |
| 31 Dec 2014 | FY | 100.0% | -779.9% | -324.0% | -101.1% | 0.67 | 1.59 | -3.4 |
| -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -82.5% | -22.1% | 1.70 | 1.35 | -1.2 |
| 31 Dec 2023 | Q4 | 83.3% | -1865.2% | -75.1% | -24.3% | 1.40 | 1.43 | -0.4 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -42.0% | -19.0% | 0.85 | 1.77 | -0.8 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -30.6% | -16.2% | 0.64 | 4.90 | -1.1 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -23.9% | -14.2% | 0.50 | 7.16 | -1.3 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -17.2% | -11.0% | 0.41 | 9.36 | -1.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -25.7% | -21.2% | 0.08 | 8.49 | -2.3 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -13.7% | -11.9% | 0.07 | 11.96 | -3.4 |